Last reviewed · How we verify

NCT05598983: DetectEx

Non-contact Proactive Remote Monitoring of COPD Exacerbations

Recruiting now Last updated 24 March 2025
What this trial tests

trial in COPD Exacerbation in 75 participants. Currently enrolling.

Timeline
15 May 2023
Primary endpoint
15 May 2026
15 May 2026

Quick facts

Lead sponsorLife Detection Technologies
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment75
Start date15 May 2023
Primary completion15 May 2026
Estimated completion15 May 2026
Sites1 location across United Kingdom

Conditions studied

Sponsor

Life Detection Technologies

Who can join

18 and older, any sex, with COPD Exacerbation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this observational study is to determine if a COPD exacerbation can be detected early in its onset. The main questions it aims to answer are: * Can an exacerbation be detected before the person recognizes they are unwell? * What are the biological signals which provide the best indication of decompensation? * How does this indication of decompensation compare to a daily CAT? Participants will be asked to place a device, DistaSense, on top of their mattress and then sleep as normal. In addition, they will be asked to complete a daily CAT.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for COPD Exacerbation

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05598983.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing